BBHvsXLVETF Comparison
VS
VanEck Biotech ETF (BBH) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. BBH's top 1 sector exposures are Healthcare. In contrast, XLV's top sector exposures are Healthcare, Consumer Non-Cyclicals and Finance. BBH is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.08% for XLV. BBH is up 32.7% year-to-date (YTD) with +$22M in YTD flows. XLV performs worse with 20.93% YTD performance, and +$2.51B in YTD flows. Run a side-by-side ETF comparison of BBH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBH vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 11/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH XLV | +4.37%+10.49% | +19.27%+13.04% | +32.70%+20.93% | +38.73%+29.11% | +68.11%+51.52% | +34.27%+50.81% |
| Flows | BBH XLV | +$15M+$2.23B | +$29M+$2.09B | +$22M+$2.51B | +$24M+$3.23B | -$123M-$1.38B | -$126M+$4.49B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH XLV | +29.42%+18.71% | +22.89%+16.94% | +20.65%+15.13% | +21.87%+15.37% |
| Max drawdown | BBH XLV | -6.32%-5.81% | -10.54%-10.51% | -22.78%-17.05% | -33.06%-17.05% |
| Max drawdown duration | BBH XLV | 36d56d | 150d116d | 440d444d | 1456d444d |
Trading data
BBH | XLV | |
Last sale 11/5/2026 at 2:30 PM | $251.01 | $184.91 |
| Previous close 11/04/2026 | $261.63 | $189.66 |
| Consolidated volume 11/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of October 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBH | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 11/5/2026 at 2:30 PM
Live
Closed
BBH | XLV | |
|---|---|---|
| Last price | $251.01 | $184.91 |
| 1D performance | -4.06% | -2.50% |
| AuM | $518.81 M | $49.93 B |
| E/R | 0.35% | 0.08% |
Characteristics
BBH | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VanEck | State Street Investment Management |
| Benchmark | MVIS US Listed Biotech 25 Index | S&P Health Care Select Sector Index |
| N° of holdings | 25 | 61 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | December 16, 1998 |
| ESG | No | No |
Exposure
Countries
BBH
USA
88.89%
Other
11.11%
XLV
USA
97.6%
Other
2.4%
Sectors
BBH
Healthcare
100%
Other
-0%
XLV
Healthcare
97.95%
Other
2.05%
Diversification
BBH
Total weight of top 15 holdings out of 15
85.93%
XLV
Total weight of top 15 holdings out of 15
71.29%
Top 15 holdings
Data as of September 30, 2026
BBH
Amgen, Inc.
15.74%
Gilead Sciences, Inc.
13.28%
Vertex Pharmaceuticals, Inc.
8.21%
Regeneron Pharmaceuticals, Inc.
6.38%
Moderna, Inc.
6.35%
Natera, Inc.
5.31%
argenx SE
4.62%
IQVIA Holdings, Inc.
4.43%
Revolution Medicines, Inc.
4.17%
Illumina, Inc.
3.99%
Guardant Health, Inc.
2.97%
Alnylam Pharmaceuticals, Inc.
2.76%
BeOne Medicines Ltd.
2.74%
Biogen, Inc.
2.73%
Incyte Corp.
2.24%
XLV
Eli Lilly & Co.
15.13%
Johnson & Johnson
10.43%
AbbVie, Inc.
7.55%
Merck & Co., Inc.
5.86%
UnitedHealth Group, Inc.
5.38%
Thermo Fisher Scientific, Inc.
4.08%
Amgen, Inc.
3.72%
Gilead Sciences, Inc.
3.02%
Abbott Laboratories
2.79%
Pfizer Inc.
2.66%
Intuitive Surgical, Inc.
2.35%
Danaher Corp.
2.27%
Vertex Pharmaceuticals, Inc.
2.17%
Bristol Myers Squibb Co.
2.08%
Medtronic Plc
1.81%
Frequently asked questions about BBH and XLV
How have the BBH and XLV ETFs performed in 2026?
As of November 5, 2026, BBH is up 32.7% year-to-date (YTD), while XLV has returned 20.93%. That puts BBH better performer ahead so far this year.
Which ETF is attracting more investor money: BBH or XLV?
Year-to-date, the BBH ETF saw +$22M in flows, compared to +$2.51B for XLV.
Which ETF is more volatile: BBH or XLV?
Over the past year, BBH had a volatility of 22.89%, while XLV experienced 16.94%.
Which ETF is bigger: BBH or XLV?
As of November 5, 2026, BBH holds $518.81 M in assets under management (AUM), while XLV manages $49.93 B.
What sectors do the BBH and XLV ETFs invest in?
BBH leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the BBH ETF and XLV ETF?
BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: BBH or XLV?
BBH holds 25 securities with 85.93% of its assets in the top 15. XLV has 61 securities and a top 15 weight of 71.29%.
Advertisement
Latest news about BBH & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
